Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), ZD1839 (‘Iressa’), in combination with 5-fluorouracil (5-FU) and leucovorin (LV), in advanced colorectal cancer (ACRC)
- 30 April 2001
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 37, S18-S19
- https://doi.org/10.1016/s0959-8049(01)80551-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: